261 related articles for article (PubMed ID: 2905912)
1. Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
Uprichard AG; Harron DW; Wilson R; Shanks RG
Br J Pharmacol; 1988 Dec; 95(4):1241-54. PubMed ID: 2905912
[TBL] [Abstract][Full Text] [Related]
2. Alpha 1-adrenergic blockade and sudden cardiac death.
Vanoli E; Hull SS; Foreman RD; Ferrari A; Schwartz PJ
J Cardiovasc Electrophysiol; 1994 Jan; 5(1):76-89. PubMed ID: 7910510
[TBL] [Abstract][Full Text] [Related]
3. Effect of alinidine on experimental cardiac arrhythmias.
Harron DW; Allen JD; Wilson R; Shanks RG
J Cardiovasc Pharmacol; 1982; 4(2):221-5. PubMed ID: 6175804
[TBL] [Abstract][Full Text] [Related]
4. Effects of lignocaine and propranolol on experimental cardiac arrhythmias.
Allen JD; Shanks RG; Zaidi SA
Br J Pharmacol; 1971 May; 42(1):1-12. PubMed ID: 4103275
[TBL] [Abstract][Full Text] [Related]
5. Effects of tiprenolol, practolol and propranolol on experimental ventricular tachyarrhythmias.
Allen JD; Shanks RG
Br J Pharmacol; 1974 Jun; 51(2):179-85. PubMed ID: 4155971
[TBL] [Abstract][Full Text] [Related]
6. MS-551 and KCB-328, two class III drugs aggravated adrenaline-induced arrhythmias.
Xue Y; Yamada C; Aye NN; Hashimoto K
Br J Pharmacol; 1998 Aug; 124(8):1712-8. PubMed ID: 9756388
[TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Mammoto T; Kamibayashi T; Hayashi Y; Yamatodani A; Takada K; Yoshiya I
Br J Pharmacol; 1996 Apr; 117(8):1744-8. PubMed ID: 8732285
[TBL] [Abstract][Full Text] [Related]
8. The effect of Kö 1173, a new anticonvulsant agent on experimental cardiac arrhythmias.
Allen JD; Ekue JM; Shanks RG; Zaidi SA
Br J Pharmacol; 1972 Aug; 45(4):561-73. PubMed ID: 5085230
[TBL] [Abstract][Full Text] [Related]
9. Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
Schafers RF; Elliott HL; Howie CA; Reid JL
Br J Clin Pharmacol; 1991 Nov; 32(5):599-604. PubMed ID: 1683249
[TBL] [Abstract][Full Text] [Related]
10. Complex adrenergic and inflammatory mechanisms contribute to phase 2 ventricular arrhythmias in anaesthetized rats.
Clements-Jewery H; Andrag E; Hearse DJ; Curtis MJ
Br J Pharmacol; 2009 Feb; 156(3):444-53. PubMed ID: 19154442
[TBL] [Abstract][Full Text] [Related]
11. An acute study of the electrophysiological and haemodynamic effects of intravenous UK-52,046, a novel alpha 1-adrenoceptor antagonist.
Barin ES; Wong CK; Elstob JE; Davies DW; Nathan AW
Br J Clin Pharmacol; 1990 Mar; 29(3):359-62. PubMed ID: 1968756
[TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic and cardiovascular effects of MP 115.
Allen JD; Deering AH; Kelly JG; Shanks RG
J Cardiovasc Pharmacol; 1983; 5(6):937-44. PubMed ID: 6196565
[TBL] [Abstract][Full Text] [Related]
13. Canine digitalis arrhythmia as a model for detecting Na-channel blocking antiarrhythmic drugs: a comparative study using other canine arrhythmia models and the new antiarrhythmic drugs, propafenone, tocainide, and SUN 1165.
Hashimoto K; Ishii M; Komori S; Mitsuhashi H
Heart Vessels; 1985 Feb; 1(1):29-35. PubMed ID: 2419304
[TBL] [Abstract][Full Text] [Related]
14. Contrastive effects of prostaglandin F2 alpha on normal cardiac rhythm and ouabain-induced cardiac arrhythmias in cats: possible neural basis.
Rao TS; Seth SD; Manchanda SC; Nayar U
Arch Int Pharmacodyn Ther; 1989; 302():128-44. PubMed ID: 2636814
[TBL] [Abstract][Full Text] [Related]
15. Esmolol prevents and suppresses arrhythmias during halothane anaesthesia in dogs.
Dimich I; Lingham R; Narang J; Sampson I; Shiang H
Can J Anaesth; 1992 Jan; 39(1):83-6. PubMed ID: 1346371
[TBL] [Abstract][Full Text] [Related]
16. UK-52,046 (a novel alpha 1-adrenoceptor antagonist) and the role of alpha-adrenoceptor stimulation and blockade on atrioventricular conduction.
Spiers JP; Harron DW; Wilson R; Allen JD
J Cardiovasc Pharmacol; 1990 Nov; 16(5):824-30. PubMed ID: 1703607
[TBL] [Abstract][Full Text] [Related]
17. Actions of a newly synthesized compound (711389-S) on various types of experimentally induced arrhythmias in mammalian species in situ.
Kadowaki Y; Ohta T; Hotokebuchi N; Kimoto S; Haruna M; Nakao T; Ueda M; Nishi K
Jpn J Pharmacol; 1988 Apr; 46(4):359-72. PubMed ID: 3404766
[TBL] [Abstract][Full Text] [Related]
18. Atenolol, but not mexiletine, protects against stimulus-induced ventricular tachycardia in a chronic canine model.
Uprichard AC; Harron DW
Br J Pharmacol; 1989 Jan; 96(1):220-6. PubMed ID: 2924074
[TBL] [Abstract][Full Text] [Related]
19. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
Hansen O; Johansson BW; Nilsson-Ehle P
Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
[TBL] [Abstract][Full Text] [Related]
20. Antiarrhythmic effect of oxprenolol on halothane-epinephrine and coronary ligation induced ventricular arrhythmias in beagle dogs.
Hashimoto K; Tsukada T; Matsuda H; Matsubara I; Imai S
Jpn J Pharmacol; 1978 Aug; 28(4):535-44. PubMed ID: 32416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
